Embodiments of the invention pertain to the field of improving the clarity of ultrasound images. Other embodiments of this invention relate to visualization methods and systems, and more specifically to systems and methods for visualizing the trajectory of a cannula or needle being inserted in a biologic subject.
The clarity of ultrasound acquired images is affected by motions of the examined subject, the motions of organs and fluids within the examined subject, the motion of the probing ultrasound transceiver, the coupling medium used transceiver and the examined subject, and the algorithms used for image processing. As regards image processing frequency domain approaches have been utilized in the literature including using Wiener filters that is implemented in the frequency domain and assumes that the point spread function (PSF) is fixed and known. This assumption conflicts with the observation that the received ultrasound signals are usually non-stationary and depth-dependent. Since the algorithm is implemented in the frequency domain, the error introduced in PSF will leak across the spatial domain. As a result, the performance of Wiener filtering is not ideal.
As regards prior uses of coupling mediums, the most common container for dispensing ultrasound coupling gel is an 8 oz. plastic squeeze bottle with an open, tapered tip. The tapered tip bottle is inexpensive and easy to refill from a larger reservoir in the form of a bag or pump-type and dispenses gel in a controlled manner. Other embodiments include the Sontac® ultrasound gel pad available from Verathon™ Medical, Bothell, Wash., USA is a pre-packaged, circular pad of moist, flexible coupling gel 2.5 inches in diameter and 0.06 inches thick and is advantageously used with the BladderScan devices. The Sontac pad is simple to apply and to remove, and provides adequate coupling for a one-position ultrasound scan in most cases. Yet others include the Aquaflex® gel pads perform in a similar manner to Sontac pads, but are larger and thicker (2 cm thick×9 cm diameter), and traditionally used for therapeutic ultrasound or where some distance between the probe and the skin surface (“stand-off”) must be maintained.
The main purpose of an ultrasonic coupling medium is to provide an air-free interface between an ultrasound transducer and the body surface. Gels are used as coupling media since they are moist and deformable, but not runny: they wet both the transducer and the body surface, but stay where they are applied. The most common delivery method for ultrasonic coupling gel, the plastic squeeze bottle, has several disadvantages. First, if the bottle has been stored upright the gel will fall to the bottom of the bottle, and vigorous shaking is required to get the gel back to the bottle tip, especially if the gel is cold. This motion can be particularly irritating to sonographers, who routinely suffer from wrist and arm pain from ultrasound scanning. Second, the bottle tip is a two-way valve: squeezing the bottle releases gel at the tip, but releasing the bottle sucks air back into the bottle and into the gel. The presence of air bubbles in the gel may detract from its performance as a coupling medium. Third, there is no standard application amount: inexperienced users such as Diagnostic Ultrasound customers have to make an educated guess about how much gel to use. Fourth, when the squeeze bottle is nearly empty it is next to impossible to coax the final 5-10% of gel into the bottle's tip for dispensing. Finally, although refilling the bottle from a central source is not a particularly difficult task, it is non-sterile and potentially messy.
Sontac pads and other solid gel coupling pads are simpler to use than gel: the user does not have to guess at an appropriate application amount, the pad is sterile, and it can be simply lifted off the patient and disposed of after use. However, pads do not mold to the skin or transducer surface as well as the more liquefied coupling gels and therefore may not provide ideal coupling when used alone, especially on dry, hairy, curved, or wrinkled surfaces. Sontac pads suffer from the additional disadvantage that they are thin and easily damaged by moderate pressure from the ultrasound transducer. (See Bishop S, Draper D O, Knight K L, Feland J B, Eggett D. “Human tissue-temperature rise during ultrasound treatments with the Aquaflex gel pad.” Journal of Athletic Training 39(2):126-131, 2004).
Relating to cannula insertion, unsuccessful insertion and/or removal of a cannula, a needle, or other similar devices into vascular tissue may cause vascular wall damage that may lead to serious complications or even death. Image guided placement of a cannula or needle into the vascular tissue reduces the risk of injury and increases the confidence of healthcare providers in using the foregoing devices. Current image guided placement methods generally use a guidance system for holding specific cannula or needle sizes. The motion and force required to disengage the cannula from the guidance system may, however, contribute to a vessel wall injury, which may result in extravasation. Complications arising from extravasation resulting in morbidity are well documented. Therefore, there is a need for image guided placement of a cannula or needle into vascular tissue while still allowing a health care practitioner to use standard “free” insertion procedures that do not require a guidance system to hold the cannula or needle.
Systems, methods, and devices for image clarity of ultrasound-based images are described. Such systems, methods, and devices include improved transducer aiming and utilizing time-domain deconvolution processes upon the non-stationary effects of ultrasound signals. The processes deconvolution applies algorithms to improve the clarity or resolution of ultrasonic images by suppressed reverberation of ultrasound echoes. The initially acquired and distorted ultrasound image is reconstructed to a clearer image by countering the effect of distortion operators. An improved point spread function (PSF) of the imaging system is applied, utilizing a deconvolution algorithm, to improve the image resolution, and remove reverberations by modeling them as noise.
As regards improved transducer aiming particular embodiments employ novel applications of computer vision techniques to perform real time analysis. First, a computer vision method is introduced: optical flow, which is a powerful motion analysis technique and is applied in many different research or commercial fields. The optical flow is able to estimate the velocity field of image series and the velocity vector provides information of the contents inside the image series. In the current field, if the target is with very large motion and the motion is in a specific pattern, like moving orientation, the velocity information inside and around the target can be different from other parts in the field. Otherwise, there will be no valuable information in current field and the scanning has to be adjusted.
As regards analyzing the motions of organ movement and fluid flows within an examined subject, new optical-flow-based methods for estimating heart motion from two-dimensional echocardiographic sequences, an optical-flow guided active contour method for Myocardial tracking in contrast echocardiography, and a method for shape-driven segmentation and tracking of the left ventricle.
As regards cannula insertion, ultrasound motion of the cannula is configured by cannula fitted with echogenic ultrasound micro reflectors.
As regards sonic coupling gel media to improve ultrasound communication between a transducer and the examined subject, embodiments include an apparatus that: dispenses a metered quantity of ultrasound coupling gel and enables one-handed gel application. The apparatus also preserves the gel in a de-gassed state (no air bubbles), preserves the gel in a sterile state (no contact between gel applicator and patient), includes a method for easy container refill, and preserves the shape and volume of existing gel application bottles.
The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawing(s) will be provided by the Patent and Trademark Office upon request and payment of the necessary fee. Embodiments for the system and method to develop, present, and use clarity enhanced ultrasound images is described below.
Systems, methods, and devices for image clarity of ultrasound-based images are described and illustrated in the following figures. The clarity of ultrasound imaging requires the efficient coordination of ultrasound transfer or communication to and from an examined subject, image acquisition from the communicated ultrasound, and microprocessor based image processing. Oftentimes the examined subject moves while image acquisition occurs, the ultrasound transducer moves, and/or movement occurs within the scanned region of interest that requires refinements as described below to secure clear images.
The ultrasound transceivers or DCD devices developed by Diagnostic Ultrasound are capable of collecting in vivo three-dimensional (3-D) cone-shaped ultrasound images of a patient. Based on these 3-D ultrasound images, various applications have been developed such as bladder volume and mass estimation.
During the data collection process initiated by DCD, a pulsed ultrasound field is transmitted into the body, and the back-scattered “echoes” are detected as a one-dimensional (1-D) voltage trace, which is also referred to as a RF line. After envelope detection, a set of 1-D data samples is interpolated to form a two-dimensional (2-D) or 3-D ultrasound image.
A directional indicator panel 22 includes a plurality of arrows that may be illuminated for initial targeting and guiding a user to access the targeting of an organ or structure within an ROI. In particular embodiments if the organ or structure is centered from placement of the transceiver 10A acoustically placed against the dermal surface at a first location of the subject, the directional arrows may be not illuminated. If the organ is off-center, an arrow or set of arrows may be illuminated to direct the user to reposition the transceiver 10A acoustically at a second or subsequent dermal location of the subject. The acrostic coupling may be achieved by liquid sonic gel applied to the skin of the patient or by sonic gel pads to which the transceiver dome 20 is placed against. The directional indicator panel 22 may be presented on the display 54 of computer 52 in harmonic imaging subsystems described in
Transceiver 10A includes an inertial reference unit that includes an accelerometer 22 and/or gyroscope 23 positioned preferably within or adjacent to housing 18. The accelerometer 22 may be operable to sense an acceleration of the transceiver 10A, preferably relative to a coordinate system, while the gyroscope 23 may be operable to sense an angular velocity of the transceiver 10A relative to the same or another coordinate system. Accordingly, the gyroscope 23 may be of conventional configuration that employs dynamic elements, or it may be an optoelectronic device, such as the known optical ring gyroscope. In one embodiment, the accelerometer 22 and the gyroscope 23 may include a commonly packaged and/or solid-state device. One suitable commonly packaged device may be the MT6 miniature inertial measurement unit, available from Omni Instruments, Incorporated, although other suitable alternatives exist. In other embodiments, the accelerometer 22 and/or the gyroscope 23 may include commonly packaged micro-electromechanical system (MEMS) devices, which are commercially available from MEMSense, Incorporated. As described in greater detail below, the accelerometer 22 and the gyroscope 23 cooperatively permit the determination of positional and/or angular changes relative to a known position that is proximate to an anatomical region of interest in the patient. Other configurations related to the accelerometer 22 and gyroscope 23 concerning transceivers 10A,B equipped with inertial reference units and the operations thereto may be obtained from copending U.S. patent application Ser. No. 11/222,360 filed Sep. 8, 2005, herein incorporated by reference.
The transceiver 10A includes (or if capable at being in signal communication with) a display 24 operable to view processed results from an ultrasound scan, and/or to allow an operational interaction between the user and the transceiver 10A. For example, the display 24 may be configured to display alphanumeric data that indicates a proper and/or an optimal position of the transceiver 10A relative to the selected anatomical portion. Display 24 may be used to view two- or three-dimensional images of the selected anatomical region. Accordingly, the display 24 may be a liquid crystal display (LCD), a light emitting diode (LED) display, a cathode ray tube (CRT) display, or other suitable display devices operable to present alphanumeric data and/or graphical images to a user.
Still referring to
To scan a selected anatomical portion of a patient, the transceiver dome 20 of the transceiver 10A may be positioned against a surface portion of a patient that is proximate to the anatomical portion to be scanned. The user actuates the transceiver 10A by depressing the trigger 14. In response, the transceiver 10 transmits ultrasound signals into the body, and receives corresponding return echo signals that may be at least partially processed by the transceiver 10A to generate an ultrasound image of the selected anatomical portion. In a particular embodiment, the transceiver 10A transmits ultrasound signals in a range that extends from approximately about two megahertz (MHz) to approximately about ten MHz.
In one embodiment, the transceiver 10A may be operably coupled to an ultrasound system that may be configured to generate ultrasound energy at a predetermined frequency and/or pulse repetition rate and to transfer the ultrasound energy to the transceiver 10A. The system also includes a processor that may be configured to process reflected ultrasound energy that is received by the transceiver 10A to produce an image of the scanned anatomical region. Accordingly, the system generally includes a viewing device, such as a cathode ray tube (CRT), a liquid crystal display (LCD), a plasma display device, or other similar display devices, that may be used to view the generated image. The system may also include one or more peripheral devices that cooperatively assist the processor to control the operation of the transceiver 10A, such a keyboard, a pointing device, or other similar devices. In still another particular embodiment, the transceiver 10A may be a self-contained device that includes a microprocessor positioned within the housing 18 and software associated with the microprocessor to operably control the transceiver 10A, and to process the reflected ultrasound energy to generate the ultrasound image. Accordingly, the display 24 may be used to display the generated image and/or to view other information associated with the operation of the transceiver 10A. For example, the information may include alphanumeric data that indicates a preferred position of the transceiver 10A prior to performing a series of scans. In yet another particular embodiment, the transceiver 10A may be operably coupled to a general-purpose computer, such as a laptop or a desktop computer that includes software that at least partially controls the operation of the transceiver 10A, and also includes software to process information transferred from the transceiver 10A, so that an image of the scanned anatomical region may be generated. The transceiver 10A may also be optionally equipped with electrical contacts to make communication with receiving cradles 50 as discussed in
Referring still to
As described above, the angular movement of the transducer may be mechanically effected and/or it may be electronically or otherwise generated. In either case, the number of lines 48 and the length of the lines may vary, so that the tilt angle φ sweeps through angles approximately between −60° and +60° for a total arc of approximately 120°. In one particular embodiment, the transceiver 10 may be configured to generate approximately about seventy-seven scan lines between the first limiting scan line 44 and a second limiting scan line 46. In another particular embodiment, each of the scan lines has a length of approximately about 18 to 20 centimeters (cm). The angular separation between adjacent scan lines 48 (
The locations of the internal and peripheral scan lines may be further defined by an angular spacing from the center scan line 34B and between internal and peripheral scan lines. The angular spacing between scan line 34B and peripheral or internal scan lines may be designated by angle Φ and angular spacings between internal or peripheral scan lines may be designated by angle Ø. The angles Φ1, Φ2, and Φ3 respectively define the angular spacings from scan line 34B to scan lines 34A, 34C, and 31D. Similarly, angles Ø1, Ø2, and Ø3 respectively define the angular spacings between scan line 31B and 31C, 31C and 34A, and 31D and 31E.
With continued reference to
Whether receiving echogenic signals from non-moving targets within the ROI from processing block 200, or moving targets within the ROI from process block 300, algorithm 120 continues with processing blocks 400A or 400B. Processing blocks 400A and 400B process echogenic datasets of the echogenic signals from process blocks 200 and 300 using a point spread function algorithms to compensate or otherwise suppress motion induced reverberations within the ROI echogenic data sets. Processing block 400A employs nonparametric analysis, and processing block 400B employs parametric analysis and described in
Referring to sub-algorithm 400B, parametric analysis employs an implementation of the CLEAN algorithm that is not iterative. Sub-algorithm 400B comprise comprises an RF line processing block 400B-2, a parametric pulse estimation block 400B-4, a CLEAN algorithm block 400B-6, a CLEAN iteration block 400B-8, and a Scan Convert processing block 400B-10. The point spread function of the transducer is estimated once and becomes a priori information used in the CLEAN algorithm. A single estimate of the pulse is applied to all RF lines in a scan plane and the CLEAN algorithm is applied once to each line. The signal output is then converted for presentation as part of a scan plane image at process block 400B-10. Sub-algorithm 400B is then completed and exits to sub-algorithms 500.
Here u in the heat filter represents the image being processed. The image u is 2D, and is comprised of an array of pixels arranged in rows along the x-axis, and an array of pixels arranged in columns along the y-axis. The pixel intensity of each pixel in the image u has an initial input image pixel intensity (I) defined as u0=I. The value of I depends on the application, and commonly occurs within ranges consistent with the application. For example, I can be as low as 0 to 1, or occupy middle ranges between 0 to 127 or 0 to 512. Similarly, I may have values occupying higher ranges of 0 to 1024 and 0 to 4096, or greater. For the shock filter u represents the image being processed whose initial value is the input image pixel intensity (I): u0=I where the l(u) term is the Laplacian of the image u, F is a function of the Laplacian, and ∥∇u∥ is the 2D gradient magnitude of image intensity defined by equation E3:
∥∇u∥=√{square root over (ux2+uy2)} E3
Where u2x=the square of the partial derivative of the pixel intensity (u) along the x-axis, u2y=the square of the partial derivative of the pixel intensity (u) along the y-axis, the Laplacian l(u) of the image, u, is expressed in equation E4:
l(u)=uxxux2+2uxyuxuy+uyyuy2 E4
Equation E9 relates to equation E6 as follows:
of u along the x-axis,
of u along the y-axis,
of u along the x-axis,
of u along the y-axis,
of u along the x-axis,
of u along the y-axis,
of u along the x and y axes, and
The combination of heat filtering and shock filtering produces an enhanced image ready to undergo the intensity-based and edge-based segmentation algorithms as discussed below. The enhanced 3D data sets are then subjected to a parallel process of intensity-based segmentation at process block 510 and edge-based segmentation at process block 512. The intensity-based segmentation step uses a “k-means” intensity clustering technique where the enhanced image is subjected to a categorizing “k-means” clustering algorithm. The “k-means” algorithm categorizes pixel intensities into white, gray, and black pixel groups. Given the number of desired clusters or groups of intensities (k), the k-means algorithm is an iterative algorithm comprising four steps: Initially determine or categorize cluster boundaries by defining a minimum and a maximum pixel intensity value for every white, gray, or black pixels into groups or k-clusters that are equally spaced in the entire intensity range. Assign each pixel to one of the white, gray or black k-clusters based on the currently set cluster boundaries. Calculate a mean intensity for each pixel intensity k-cluster or group based on the current assignment of pixels into the different k-clusters. The calculated mean intensity is defined as a cluster center. Thereafter, new cluster boundaries are determined as mid points between cluster centers. The fourth and final step of intensity-based segmentation determines if the cluster boundaries significantly change locations from their previous values. Should the cluster boundaries change significantly from their previous values, iterate back to step 2, until the cluster centers do not change significantly between iterations. Visually, the clustering process is manifest by the segmented image and repeated iterations continue until the segmented image does not change between the iterations.
The pixels in the cluster having the lowest intensity value—the darkest cluster—are defined as pixels associated with internal cavity regions of bladders. For the 2D algorithm, each image is clustered independently of the neighboring images. For the 3D algorithm, the entire volume is clustered together. To make this step faster, pixels are sampled at 2 or any multiple sampling rate factors before determining the cluster boundaries. The cluster boundaries determined from the down-sampled data are then applied to the entire data.
The edge-based segmentation process block 512 uses a sequence of four sub-algorithms. The sequence includes a spatial gradients algorithm, a hysteresis threshold algorithm, a Region-of-Interest (ROI) algorithm, and a matching edges filter algorithm. The spatial gradient algorithm computes the x-directional and y-directional spatial gradients of the enhanced image. The hysteresis threshold algorithm detects salient edges. Once the edges are detected, the regions defined by the edges are selected by a user employing the ROI algorithm to select regions-of-interest deemed relevant for analysis.
Since the enhanced image has very sharp transitions, the edge points can be easily determined by taking x- and y-derivatives using backward differences along x- and y-directions. The pixel gradient magnitude ∥∇I∥ is then computed from the x- and y-derivative image in equation E5 as:
∥∇I∥=√{square root over (Ix2+Iy2)} E5
Where I2x=the square of x-derivative of intensity and I2y=the square of y-derivative of intensity along the y-axis.
Significant edge points are then determined by thresholding the gradient magnitudes using a hysteresis thresholding operation. Other thresholding methods could also be used. In hysteresis thresholding, two threshold values, a lower threshold and a higher threshold, are used. First, the image is thresholded at the lower threshold value and a connected component labeling is carried out on the resulting image. Next, each connected edge component is preserved which has at least one edge pixel having a gradient magnitude greater than the upper threshold. This kind of thresholding scheme is good at retaining long connected edges that have one or more high gradient points.
In the preferred embodiment, the two thresholds are automatically estimated. The upper gradient threshold is estimated at a value such that at most 97% of the image pixels are marked as non-edges. The lower threshold is set at 50% of the value of the upper threshold. These percentages could be different in different implementations. Next, edge points that lie within a desired region-of-interest are selected. This region of interest algorithm excludes points lying at the image boundaries and points lying too close to or too far from the transceivers 10A,B. Finally, the matching edge filter is applied to remove outlier edge points and fill in the area between the matching edge points.
The edge-matching algorithm is applied to establish valid boundary edges and remove spurious edges while filling the regions between boundary edges. Edge points on an image have a directional component indicating the direction of the gradient. Pixels in scanlines crossing a boundary edge location can exhibit two gradient transitions depending on the pixel intensity directionality. Each gradient transition is given a positive or negative value depending on the pixel intensity directionality. For example, if the scanline approaches an echo reflective bright wall from a darker region, then an ascending transition is established as the pixel intensity gradient increases to a maximum value, i.e., as the transition ascends from a dark region to a bright region. The ascending transition is given a positive numerical value. Similarly, as the scanline recedes from the echo reflective wall, a descending transition is established as the pixel intensity gradient decreases to or approaches a minimum value. The descending transition is given a negative numerical value.
Valid boundary edges are those that exhibit ascending and descending pixel intensity gradients, or equivalently, exhibit paired or matched positive and negative numerical values. The valid boundary edges are retained in the image. Spurious or invalid boundary edges do not exhibit paired ascending-descending pixel intensity gradients, i.e., do not exhibit paired or matched positive and negative numerical values. The spurious boundary edges are removed from the image.
For bladder cavity volumes, most edge points for blood fluid surround a dark, closed region, with directions pointing inwards towards the center of the region. Thus, for a convex-shaped region, the direction of a gradient for any edge point, the edge point having a gradient direction approximately opposite to the current point represents the matching edge point. Those edge points exhibiting an assigned positive and negative value are kept as valid edge points on the image because the negative value is paired with its positive value counterpart. Similarly, those edge point candidates having unmatched values, i.e., those edge point candidates not having a negative-positive value pair, are deemed not to be true or valid edge points and are discarded from the image.
The matching edge point algorithm delineates edge points not lying on the boundary for removal from the desired dark regions. Thereafter, the region between any two matching edge points is filled in with non-zero pixels to establish edge-based segmentation. In a preferred embodiment of the invention, only edge points whose directions are primarily oriented co-linearly with the scanline are sought to permit the detection of matching front wall and back wall pairs of a bladder cavity, for example the left or right ventricle.
Referring again to
After combining the segmentation results, the combined pixel information in the 3D data sets In a fifth process is cleaned at process block 516 to make the output image smooth and to remove extraneous structures not relevant to bladder cavities. Cleanup 516 includes filling gaps with pixels and removing pixel groups unlikely to be related to the ROI undergoing study, for example pixel groups unrelated to bladder cavity structures. Sub-algorithm 500 is then completed and exits to sub-algorithm 600.
An embodiment related to cannula insertion generally includes an ultrasound probe attached to a first camera and a second camera and a processing and display generating system that is in signal communication with the ultrasound probe, the first camera, and/or the second camera. A user of the system scans tissue containing a target vein using the ultrasound probe and a cross-sectional image of the target vein is displayed. The first camera records a first image of a cannula in a first direction and the second camera records a second image of the cannula in a second direction orthogonal to the first direction. The first and/or the second images are processed by the processing and display generating system along with the relative positions of the ultrasound probe, the first camera, and/or the second camera to determine the trajectory of the cannula. A representation of the determined trajectory of the cannula is then displayed on the ultrasound image.
First, a user employs the ultrasound probe 1010 and the processing and display generating system 1061 to generate a cross-sectional image of a patient's arm tissue containing a vein to be cannulated (“target vein”) 1019. This could be done by one of the methods disclosed in the related patents and/or patent applications which are herein incorporated by reference, for example. The user then identifies the target vein 1019 in the image using methods such as simple compression which differentiates between arteries and/or veins by using the fact that veins collapse easily while arteries do not. After the user has identified the target vein 1019, the ultrasound probe 1010 is affixed to the patient's arm over the previously identified target vein 19 using a magnetic tape material 1012. The ultrasound probe 1010 and the processing and display generating system 1061 continue to generate a 2D cross-sectional image of the tissue containing the target vein 1019. Images from the cameras 1014, 1018 are provided to the processing and display generating system 1061 as the cannula 1020 is approaching and/or entering the arm of the patient.
The processing and display generating system 1061 locates the cannula 1020 in the images provided by the cameras 1014, 1018 and determines the projected location at which the cannula 1020 will penetrate the cross-sectional ultrasound image being displayed. The trajectory of the cannula 1020 is determined in some embodiments by using image processing to identify bright spots corresponding to micro reflectors previously machined into the shaft of the cannula 1020 or a needle used alone or in combination with the cannula 1020. Image processing uses the bright spots to determine the angles of the cannula 1020 relative to the cameras 1014, 1018 and then generates a projected trajectory by using the determined angles and/or the known positions of the cameras 1014, 1018 in relation to the ultrasound probe 10. In other embodiments, determination of the cannula 1020 trajectory is performed using edge-detection algorithms in combination with the known positions of the cameras 1014, 1018 in relation to the ultrasound probe 1010, for example.
The projected location may be indicated on the displayed image as a computer-generated cross-hair 1066, the intersection of which is where the cannula 1020 is projected to penetrate the image. When the cannula 1020 does penetrate the cross-sectional plane of the scan produced by the ultrasound probe 1010, the ultrasound image confirms that the cannula 1020 penetrated at the location of the cross-hair 1066. This gives the user a real-time ultrasound image of the target vein 1019 with an overlaid real-time computer-generated image of the position in the ultrasound image that the cannula 1020 will penetrate. This allows the user to adjust the location and/or angle of the cannula 1020 before and/or during insertion to increase the likelihood they will penetrate the target vein 1019. Risks of pneumothorax and other adverse outcomes should be substantially reduced since a user will be able to use normal “free” insertion procedures but have the added knowledge of knowing where the cannula 1020 trajectory will lead.
The processing and display generating system 1061 is composed of a display 1064 and a block 1062 containing a computer, a digital signal processor (DSP), and analog to digital (A/D) converters. As discussed for
While the preferred embodiment of the invention has been illustrated and described, as noted above, many changes can be made without departing from the spirit and scope of the invention. For example, a three dimensional ultrasound system could be used rather than a 2D system. In addition, different numbers of cameras could be used along with image processing that determines the cannula 1020 trajectory based on the number of cameras used. The two cameras 1014, 1018 could also be placed in a non-orthogonal relationship so long as the image processing was adjusted to properly determine the orientation and/or projected trajectory of the cannula 1020. Also, an embodiment of the invention could be used for needles and/or other devices which are to be inserted in the body of a patient. Additionally, an embodiment of the invention could be used in places other than arm veins. Regions of the patient's body other than an arm could be used and/or biological structures other than veins may be the focus of interest. As regards ultrasound-based algorithms, alternate embodiments may be configured to image acquisitions other than ultrasound, for example X-ray, visible and infrared light acquired images. Accordingly, the scope of the invention is not limited by the disclosure of the preferred embodiment.
This application incorporates by reference and claims priority to U.S. provisional patent application Ser. No. 11/625,805 filed Jan. 22, 2007. This application incorporates by reference and claims priority to U.S. provisional patent application Ser. No. 60/882,888 filed Dec. 29, 2006. This application incorporates by reference and claims priority to U.S. provisional patent application Ser. No. 60/828,614 filed Oct. 6, 2006. This application incorporates by reference and claims priority to U.S. provisional patent application Ser. No. 60/760,677 filed Jan. 20, 2006. This application incorporates by reference and claims priority to U.S. provisional patent application Ser. No. 60/778,634 filed Mar. 1, 2006. This application is a continuation-in-part of and claims priority to U.S. patent application Ser. No. 11/213,284 filed Aug. 26, 2005. This application claims priority to and is a continuation-in-part of U.S. patent application Ser. No. 11/119,355 filed Apr. 29, 2005, which claims priority to U.S. provisional patent application Ser. No. 60/566,127 filed Apr. 30, 2004. This application also claims priority to and is a continuation-in-part of U.S. patent application Ser. No. 10/701,955 filed Nov. 5, 2003, which in turn claims priority to and is a continuation-in-part of U.S. patent application Ser. No. 10/443,126 filed May 20, 2003. This application claims priority to and is a continuation-in-part of U.S. patent application Ser. No. 11/061,867 filed Feb. 17, 2005, which claims priority to U.S. provisional patent application Ser. No. 60/545,576 filed Feb. 17, 2004 and U.S. provisional patent application Ser. No. 60/566,818 filed Apr. 30, 2004. This application is also a continuation-in-part of and claims priority to U.S. patent application Ser. No. 11/222,360 filed Sep. 8, 2005. This application is also a continuation-in-part of and claims priority to U.S. patent application Ser. No. 11/061,867 filed Feb. 17, 2005. This application is also a continuation-in-part of and claims priority to U.S. patent application Ser. No. 10/704,966 filed Nov. 10, 2004. This application claims priority to and is a continuation-in-part of U.S. patent application Ser. No. 10/607,919 filed Jun. 27, 2005. This application is a continuation-in-part of and claims priority to PCT application serial number PCT/US03/24368 filed Aug. 1, 2003, which claims priority to U.S. provisional patent application Ser. No. 60/423,881 filed Nov. 5, 2002 and U.S. provisional patent application Ser. No. 60/400,624 filed Aug. 2, 2002. This application is also a continuation-in-part of and claims priority to PCT Application Serial No. PCT/US03/14785 filed May 9, 2003, which is a continuation of U.S. patent application Ser. No. 10/165,556 filed Jun. 7, 2002. This application is also a continuation-in-part of and claims priority to U.S. patent application Ser. No. 10/888,735 filed Jul. 9, 2004. This application is also a continuation-in-part of and claims priority to U.S. patent application Ser. No. 10/633,186 filed Jul. 31, 2003 which claims priority to U.S. provisional patent application Ser. No. 60/423,881 filed Nov. 5, 2002 and to U.S. patent application Ser. No. 10/443,126 filed May 20, 2003 which claims priority to U.S. provisional patent application Ser. No. 60/423,881 filed Nov. 5, 2002 and to U.S. provisional application 60/400,624 filed Aug. 2, 2002. All of the above applications are incorporated by reference in their entirety as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
3613069 | Cary, Jr. et al. | Oct 1971 | A |
4431007 | Amazeen et al. | Feb 1984 | A |
4556066 | Semrow | Dec 1985 | A |
4757821 | Snyder | Jul 1988 | A |
4771205 | Mequio | Sep 1988 | A |
4821210 | Rumbaugh | Apr 1989 | A |
4844080 | Frass et al. | Jul 1989 | A |
4926871 | Ganguly et al. | May 1990 | A |
5058591 | Companion et al. | Oct 1991 | A |
5060515 | Kanda et al. | Oct 1991 | A |
5078149 | Katsumata et al. | Jan 1992 | A |
5125410 | Misono et al. | Jun 1992 | A |
5148809 | Biegeleisen-Knight et al. | Sep 1992 | A |
5151856 | Halmann et al. | Sep 1992 | A |
5159931 | Pini | Nov 1992 | A |
5197019 | Delon-Martin et al. | Mar 1993 | A |
5235985 | McMorrow et al. | Aug 1993 | A |
5265614 | Hayakawa et al. | Nov 1993 | A |
5299577 | Brown et al. | Apr 1994 | A |
5381794 | Tei et al. | Jan 1995 | A |
5432310 | Stoeger | Jul 1995 | A |
5435310 | Sheehan et al. | Jul 1995 | A |
5465721 | Kishimoto et al. | Nov 1995 | A |
5473555 | Potter | Dec 1995 | A |
5487388 | Rello et al. | Jan 1996 | A |
5503152 | Oakley et al. | Apr 1996 | A |
5503153 | Liu et al. | Apr 1996 | A |
5526816 | Arditi | Jun 1996 | A |
5553618 | Suzuki et al. | Sep 1996 | A |
5575286 | Weng et al. | Nov 1996 | A |
5575291 | Hayakawa et al. | Nov 1996 | A |
5577506 | Dias | Nov 1996 | A |
5588435 | Weng et al. | Dec 1996 | A |
5601084 | Sheehan et al. | Feb 1997 | A |
5605155 | Chalana et al. | Feb 1997 | A |
5615680 | Sano | Apr 1997 | A |
5644513 | Rudin et al. | Jul 1997 | A |
5645077 | Foxlin | Jul 1997 | A |
5697525 | O'Reilly et al. | Dec 1997 | A |
5698549 | Steers et al. | Dec 1997 | A |
5724101 | Haskin | Mar 1998 | A |
5735282 | Hossack | Apr 1998 | A |
5738097 | Beach et al. | Apr 1998 | A |
5776063 | Dittrich et al. | Jul 1998 | A |
5782767 | Pretlow, III | Jul 1998 | A |
5806521 | Morimoto et al. | Sep 1998 | A |
5841889 | Seyed-Bolorforosh | Nov 1998 | A |
5846202 | Ramamurthy et al. | Dec 1998 | A |
5851186 | Wood et al. | Dec 1998 | A |
5873829 | Kamiyama et al. | Feb 1999 | A |
5892843 | Zhou et al. | Apr 1999 | A |
5898793 | Karron et al. | Apr 1999 | A |
5903664 | Hartley et al. | May 1999 | A |
5908390 | Matsushima | Jun 1999 | A |
5913823 | Hedberg et al. | Jun 1999 | A |
5928151 | Hossack et al. | Jul 1999 | A |
5945770 | Hanafy | Aug 1999 | A |
5964710 | Ganguly et al. | Oct 1999 | A |
5971923 | Finger | Oct 1999 | A |
5972023 | Tanner et al. | Oct 1999 | A |
5980459 | Chiao et al. | Nov 1999 | A |
5993390 | Savord et al. | Nov 1999 | A |
6008813 | Lauer et al. | Dec 1999 | A |
6030344 | Guracar et al. | Feb 2000 | A |
6042545 | Hossack et al. | Mar 2000 | A |
6048312 | Ishrak et al. | Apr 2000 | A |
6063033 | Haider et al. | May 2000 | A |
6064906 | Langberg et al. | May 2000 | A |
6071242 | Lin | Jun 2000 | A |
6102858 | Hatfield et al. | Aug 2000 | A |
6106465 | Napolitano et al. | Aug 2000 | A |
6110111 | Barnard | Aug 2000 | A |
6117080 | Schwartz | Sep 2000 | A |
6122538 | Sliwa, Jr. et al. | Sep 2000 | A |
6123669 | Kanda | Sep 2000 | A |
6126598 | Entrekin et al. | Oct 2000 | A |
6142942 | Clark | Nov 2000 | A |
6146330 | Tujino et al. | Nov 2000 | A |
6148095 | Prause et al. | Nov 2000 | A |
6151404 | Pieper | Nov 2000 | A |
6159150 | Yale et al. | Dec 2000 | A |
6171248 | Hossack et al. | Jan 2001 | B1 |
6193657 | Drapkin | Feb 2001 | B1 |
6200266 | Shokrollahi et al. | Mar 2001 | B1 |
6210327 | Brackett et al. | Apr 2001 | B1 |
6213949 | Ganguly et al. | Apr 2001 | B1 |
6213951 | Krishnan et al. | Apr 2001 | B1 |
6222948 | Hossack et al. | Apr 2001 | B1 |
6233480 | Hochman et al. | May 2001 | B1 |
6238344 | Gamelsky et al. | May 2001 | B1 |
6248070 | Kanda et al. | Jun 2001 | B1 |
6254539 | Pang et al. | Jul 2001 | B1 |
6264609 | Herrington et al. | Jul 2001 | B1 |
6272469 | Koritzinsky et al. | Aug 2001 | B1 |
6277073 | Bolorforosh et al. | Aug 2001 | B1 |
6286513 | Au et al. | Sep 2001 | B1 |
6302845 | Shi et al. | Oct 2001 | B2 |
6309353 | Cheng et al. | Oct 2001 | B1 |
6325758 | Carol et al. | Dec 2001 | B1 |
6338716 | Hossack et al. | Jan 2002 | B1 |
6343936 | Kaufman et al. | Feb 2002 | B1 |
6346124 | Geiser et al. | Feb 2002 | B1 |
6350239 | Ohad et al. | Feb 2002 | B1 |
6359190 | Ter-Ovanesyan et al. | Mar 2002 | B1 |
6360027 | Hossack et al. | Mar 2002 | B1 |
6375616 | Soferman et al. | Apr 2002 | B1 |
6400848 | Gallagher | Jun 2002 | B1 |
6402762 | Hunter et al. | Jun 2002 | B2 |
6406431 | Barnard et al. | Jun 2002 | B1 |
6409665 | Scott et al. | Jun 2002 | B1 |
6440071 | Slayton et al. | Aug 2002 | B1 |
6440072 | Schuman et al. | Aug 2002 | B1 |
6443894 | Sumanaweera et al. | Sep 2002 | B1 |
6468218 | Chen et al. | Oct 2002 | B1 |
6485423 | Angelsen et al. | Nov 2002 | B2 |
6491631 | Chiao et al. | Dec 2002 | B2 |
6494841 | Thomas et al. | Dec 2002 | B1 |
6503204 | Sumanaweera et al. | Jan 2003 | B1 |
6511325 | Lalka et al. | Jan 2003 | B1 |
6511426 | Hossack et al. | Jan 2003 | B1 |
6511427 | Sliwa, Jr. et al. | Jan 2003 | B1 |
6515657 | Zanelli | Feb 2003 | B1 |
6524249 | Moehring et al. | Feb 2003 | B2 |
6535759 | Epstein et al. | Mar 2003 | B1 |
6540679 | Slayton et al. | Apr 2003 | B2 |
6544179 | Schmiesing et al. | Apr 2003 | B1 |
6545678 | Ohazama | Apr 2003 | B1 |
6551246 | Ustuner et al. | Apr 2003 | B1 |
6565512 | Ganguly et al. | May 2003 | B1 |
6569097 | McMorrow et al. | May 2003 | B1 |
6569101 | Quistgaard et al. | May 2003 | B2 |
6575907 | Soferman et al. | Jun 2003 | B1 |
6585647 | Winder | Jul 2003 | B1 |
6610013 | Fenster et al. | Aug 2003 | B1 |
6611141 | Schulz et al. | Aug 2003 | B1 |
6622560 | Song et al. | Sep 2003 | B2 |
6628743 | Drummond et al. | Sep 2003 | B1 |
6643533 | Knoplioch et al. | Nov 2003 | B2 |
6650927 | Keidar | Nov 2003 | B1 |
6676605 | Barnard et al. | Jan 2004 | B2 |
6682473 | Matsuura et al. | Jan 2004 | B1 |
6688177 | Wiesauer | Feb 2004 | B2 |
6695780 | Nahum et al. | Feb 2004 | B1 |
6705993 | Ebbini et al. | Mar 2004 | B2 |
6716175 | Geiser et al. | Apr 2004 | B2 |
6752762 | DeJong et al. | Jun 2004 | B1 |
6755787 | Hossack et al. | Jun 2004 | B2 |
6768811 | Dinstein et al. | Jul 2004 | B2 |
6780152 | Ustuner et al. | Aug 2004 | B2 |
6788620 | Shiraishi et al. | Sep 2004 | B2 |
6801643 | Pieper | Oct 2004 | B2 |
6822374 | Smith et al. | Nov 2004 | B1 |
6825838 | Smith et al. | Nov 2004 | B2 |
6831394 | Baumgartner et al. | Dec 2004 | B2 |
6868594 | Gururaja | Mar 2005 | B2 |
6884217 | McMorrow et al. | Apr 2005 | B2 |
6903813 | Jung et al. | Jun 2005 | B2 |
6905467 | Bradley et al. | Jun 2005 | B2 |
6905468 | McMorrow et al. | Jun 2005 | B2 |
6911912 | Roe | Jun 2005 | B2 |
6936009 | Venkataramani et al. | Aug 2005 | B2 |
6939301 | Abdelhak | Sep 2005 | B2 |
6951540 | Ebbini et al. | Oct 2005 | B2 |
6954406 | Jones | Oct 2005 | B2 |
6961405 | Scherch | Nov 2005 | B2 |
6962566 | Quistgaard et al. | Nov 2005 | B2 |
6970091 | Roe | Nov 2005 | B2 |
7004904 | Chalana et al. | Feb 2006 | B2 |
7025725 | Dione et al. | Apr 2006 | B2 |
7041059 | Chalana et al. | May 2006 | B2 |
7042386 | Woodford et al. | May 2006 | B2 |
7087022 | Chalana et al. | Aug 2006 | B2 |
7141020 | Poland et al. | Nov 2006 | B2 |
7142905 | Slayton et al. | Nov 2006 | B2 |
7177677 | Kaula et al. | Feb 2007 | B2 |
7189205 | McMorrow et al. | Mar 2007 | B2 |
7201715 | Burdette et al. | Apr 2007 | B2 |
7215277 | Woodford et al. | May 2007 | B2 |
7255678 | Mehi et al. | Aug 2007 | B2 |
7301636 | Jung et al. | Nov 2007 | B2 |
7382907 | Luo et al. | Jun 2008 | B2 |
7450746 | Yang et al. | Nov 2008 | B2 |
7520857 | Chalana et al. | Apr 2009 | B2 |
7611466 | Chalana et al. | Nov 2009 | B2 |
20010031920 | Kaufman et al. | Oct 2001 | A1 |
20020005071 | Song et al. | Jan 2002 | A1 |
20020016545 | Quistgaard et al. | Feb 2002 | A1 |
20020072671 | Chenal et al. | Jun 2002 | A1 |
20020102023 | Yamauchi et al. | Aug 2002 | A1 |
20020133075 | Abdelhak | Sep 2002 | A1 |
20020147399 | Mao et al. | Oct 2002 | A1 |
20020165448 | Ben-Haim et al. | Nov 2002 | A1 |
20030055336 | Buck et al. | Mar 2003 | A1 |
20030142587 | Zeitzew | Jul 2003 | A1 |
20030174872 | Chalana et al. | Sep 2003 | A1 |
20030181806 | Medan et al. | Sep 2003 | A1 |
20030216646 | Angelsen et al. | Nov 2003 | A1 |
20030229281 | Barnard et al. | Dec 2003 | A1 |
20040006266 | Ustuner et al. | Jan 2004 | A1 |
20040024302 | Chalana et al. | Feb 2004 | A1 |
20040034305 | Song et al. | Feb 2004 | A1 |
20040054280 | McMorrow et al. | Mar 2004 | A1 |
20040076317 | Roberts | Apr 2004 | A1 |
20040106869 | Tepper | Jun 2004 | A1 |
20040127796 | Chalana et al. | Jul 2004 | A1 |
20040127797 | Barnard et al. | Jul 2004 | A1 |
20040267123 | McMorrow et al. | Dec 2004 | A1 |
20050135707 | Turek et al. | Jun 2005 | A1 |
20050174324 | Liberty et al. | Aug 2005 | A1 |
20050193820 | Sheljaskow et al. | Sep 2005 | A1 |
20050212757 | Marvit et al. | Sep 2005 | A1 |
20050215896 | McMorrow et al. | Sep 2005 | A1 |
20050228276 | He et al. | Oct 2005 | A1 |
20050240126 | Foley et al. | Oct 2005 | A1 |
20050253806 | Liberty et al. | Nov 2005 | A1 |
20060025689 | Chalana et al. | Feb 2006 | A1 |
20060064010 | Cannon, Jr. et al. | Mar 2006 | A1 |
20060078501 | Goertz et al. | Apr 2006 | A1 |
20060079775 | McMorrow et al. | Apr 2006 | A1 |
20060111633 | McMorrow et al. | May 2006 | A1 |
20060235301 | Chalana et al. | Oct 2006 | A1 |
20070004983 | Chalana et al. | Jan 2007 | A1 |
20070232908 | Wang et al. | Oct 2007 | A1 |
20070276247 | Chalana et al. | Nov 2007 | A1 |
20070276254 | Yang et al. | Nov 2007 | A1 |
20080139938 | Yang et al. | Jun 2008 | A1 |
20080146932 | Chalana et al. | Jun 2008 | A1 |
20080242985 | Chalana et al. | Oct 2008 | A1 |
20080249414 | Yang et al. | Oct 2008 | A1 |
20080262356 | Chalana et al. | Oct 2008 | A1 |
20090062644 | McMorrow et al. | Mar 2009 | A1 |
20090088660 | McMorrow et al. | Apr 2009 | A1 |
20090105585 | Wang et al. | Apr 2009 | A1 |
20090112089 | Barnard et al. | Apr 2009 | A1 |
20090264757 | Yang et al. | Oct 2009 | A1 |
Number | Date | Country |
---|---|---|
0 271 214 | Jun 1988 | EP |
1 030 187 | Aug 2000 | EP |
1 076 318 | Feb 2001 | EP |
2 391 625 | Feb 2004 | GB |
7-171149 | Jul 1995 | JP |
2000-210286 | Aug 2000 | JP |
2000-126178 | Sep 2000 | JP |
2000-126181 | Sep 2000 | JP |
2000-126182 | Sep 2000 | JP |
0135339 | May 2001 | WO |
2009032778 | Mar 2009 | WO |
Number | Date | Country | |
---|---|---|---|
20070232908 A1 | Oct 2007 | US |
Number | Date | Country | |
---|---|---|---|
60882888 | Dec 2006 | US | |
60828614 | Oct 2006 | US | |
60760677 | Jan 2006 | US | |
60778634 | Mar 2006 | US | |
60566127 | Apr 2004 | US | |
60545576 | Feb 2004 | US | |
60566818 | Apr 2004 | US | |
60423881 | Nov 2002 | US | |
60400624 | Aug 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10165556 | Jun 2002 | US |
Child | PCT/US03/14785 | US | |
Parent | 11680380 | US | |
Child | PCT/US03/14785 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11213284 | Aug 2005 | US |
Child | 11680380 | US | |
Parent | 11119355 | Apr 2005 | US |
Child | 11213284 | US | |
Parent | 10701955 | Nov 2003 | US |
Child | 11119355 | US | |
Parent | 10443126 | May 2003 | US |
Child | 10701955 | US | |
Parent | 11680380 | US | |
Child | 10701955 | US | |
Parent | 11061867 | Feb 2005 | US |
Child | 11680380 | US | |
Parent | 11222360 | Sep 2005 | US |
Child | 11061867 | US | |
Parent | 11061867 | Feb 2005 | US |
Child | 11222360 | US | |
Parent | 10704966 | Nov 2004 | US |
Child | 11061867 | US | |
Parent | 10607919 | Jun 2005 | US |
Child | 10704966 | US | |
Parent | PCT/US03/24368 | Aug 2003 | US |
Child | 10607919 | US | |
Parent | PCT/US03/14785 | May 2003 | US |
Child | PCT/US03/24368 | US | |
Parent | 10888735 | Jul 2004 | US |
Child | 11680380 | US | |
Parent | 10633186 | Jul 2003 | US |
Child | 10888735 | US |